Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke

S. Teramoto, H. Yamamoto, Y. Yamaguchi, Y. Hanaoka, M. Ishii, S. Hibi, Y. Ouchi
European Respiratory Journal 2007 29: 218-219; DOI: 10.1183/09031936.00115106
S. Teramoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Yamaguchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Hanaoka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Ishii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Hibi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Ouchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

In a recent issue of the European Respiratory Journal, van de Garde et al. 1 demonstrated that the use of angiotensin-converting enzyme (ACE) inhibitors is not associated with a decreased risk of hospitalisation for community-acquired pneumonia (CAP) in a general, essentially white population. Their conclusion that the beneficial effect of ACE inhibitors on pneumonia risk is not observed in a general white population is in contrast with previous findings in Asian populations 1. This was an excellent good study examining the association of ACE inhibitor treatment of cardiovascular disease with a risk reduction of CAP using a large sample size. The results are acceptable and not surprising; however, the discussion and conclusion are misleading.

As shown in table 1⇓, there are controversies regarding the ACE inhibitor effects on the risk reduction of pneumonia even in Asian countries; furthermore, the study samples are very different among the studies. In a prospective study by Sekizawa et al. 2, ACE inhibitor use reduced pneumonia incidence for 2 yrs. They did not examine the general population; subjects were hypertensive elderly patients with a history of stroke or lacuna infarction, and a mean age 10 yrs older than that of the study by van de Garde et al. 1. However, the study by Arai et al. 3 examined the association of ACE inhibitors and the risk reduction of pneumonia in the general hypertensive elderly without stroke in Japan 3. Surprisingly, they had an 8.3–8.9% incidence of pneumonia over 3 yrs, an incidence twenty times higher than the previous data 6, 7. It is hard to believe that ∼3% of hypertensive elderly outpatients without major complications suffered from pneumonia. We have previously presented data showing no association of ACE inhibitor use with pneumonia risk in elderly hypertensive subjects without stroke history 4. Since ACE inhibitors, through the inactivation substance P, improve upper airway reflexes such as swallowing and cough, resulting in the reduction of aspiration pneumonia in elderly patients, they may not reduce the CAP in those patients without deglutition problems. Current evidence indicates that ACE inhibitors play a significant role in the prevention of aspiration pneumonia in the elderly, but not in common CAP in healthy adults. This was confirmed by the sub-analysis of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). Ohkubo et al. 5 re-analysed the PROGRESS data concerning the incidence of pneumonia. ACE inhibitor-active treatment significantly reduced the risk of pneumonia among participants of Asian ethnicity (mean (95% confidence interval) 47% (14–67%), p = 0.01), with no significant effect among non-Asian participants (5% (-27–29%), p = 0.7; p for homogeneity = 0.04). These findings add to the body of evidence regarding the effects of these drugs on pneumonia. The randomised design of PROGRESS greatly reduced the likelihood of confounding of the analyses and provided an excellent opportunity to explore the validity of the associations reported in observational studies 2, 3. Thus, the key issue is the selection of elderly subjects in terms of ethnicity, post-stroke state, performance status, type of ACE inhibitor and swallowing function.

View this table:
  • View inline
  • View popup
Table 1—

The association of angiotensin-converting enzyme (ACE) inhibitor use and the rate of pneumonia in different trials

The clinical epidemiology research group of Etminan et al. 8 recently reported that no association was found between the use of ACE inhibitors or angiotensin II receptor blockers (ARBs) and risk of hospitalisation secondary to CAP. The study further confirmed the limited efficacy of ACE inhibitors on the risk reduction of hospitalisation due to pneumonia in a white population. As we speculated, ARBs did not have any role in the prevention of aspiration pneumonia.

Stroke and post-stroke patients often exhibit a normal cough reflex, but not swallowing reflex, and the small volume of aspirated materials due to impaired swallowing during night is a key factor for the risk of pneumonia 9, 10. Hence, a ten times higher rate of pneumonia in post-stroke patients without significant neurological deficit, compared with the rate of pneumonia in normal elderly 5. Furthermore, the age-dependent impairment of upper airway reflexes should be carefully considered for the mechanism of CAP in the elderly irrespective of the history of stroke.

Finally, we emphasise that aspiration and silent aspiration are very important mechanisms of aspiration pneumonia. Silent aspiration is very common in patients with stroke and frail elderly patients, and nasogastric tube feeding without swallowing rehabilitation or oral care cannot reduce the pneumonia risk in patients with swallowing disorders 11.

We believe that angiotensin-converting enzyme inhibitors could prevent aspiration pneumonia in selected elderly patients. Post-stroke and the frail elderly are the best candidates for the pneumonia risk reduction by angiotensin-converting enzyme inhibitors 12. However, these merits may not be consistently observed in Caucasian elderly patients with or without stroke.

    • © ERS Journals Ltd

    References

    1. ↵
      van de Garde EM, Souverein PC, van den Bosch JM, Deneer VH, Leufkens HG. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J 2006;27:1217–1222.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet 1998;352:1069
      OpenUrlPubMedWeb of Science
    3. ↵
      Arai T, Yasuda Y, Toshima S, Yoshimi N, Kashiki Y. ACE inhibitors and pneumonia in elderly people. Lancet 1998;352:1937–1938.
      OpenUrlPubMedWeb of Science
    4. ↵
      Teramoto S, Ouchi Y. ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives. Lancet 1999;353:843
      OpenUrlPubMedWeb of Science
    5. ↵
      Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 2004;169:1041–1045.
      OpenUrlCrossRefPubMedWeb of Science
    6. ↵
      Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1:671–674.
      OpenUrlCrossRefPubMedWeb of Science
    7. ↵
      Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993;137:977–988.
      OpenUrlAbstract/FREE Full Text
    8. ↵
      Etminan M, Zhang B, Fitzgerald M, Brophy JM. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study. Pharmacotherapy 2006;26:479–482.
      OpenUrlCrossRefPubMedWeb of Science
    9. ↵
      Teramoto S, Ishii T, Yamamoto H, et al. Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia. Eur Respir J 2005;25:210–211.
      OpenUrlFREE Full Text
    10. ↵
      Teramoto S, Matsuse T, Fukuchi Y, Ouchi Y. Simple two-step swallowing provocation test for elderly patients with aspiration pneumonia. Lancet 1999;353:1243
      OpenUrlPubMedWeb of Science
    11. ↵
      Teramoto S, Ishii T, Yamamoto H, Yamaguchi Y, Ouchi Y. Nasogastric tube feeding is a cause of aspiration pneumonia in ventilated patients. Eur Respir J 2006;27:436–437.
      OpenUrlFREE Full Text
    12. ↵
      Teramoto S, Kume H, Fukuchi Y. Antihypertensive drugs in Japan. Lancet 2001;357:720–721.
      OpenUrlPubMedWeb of Science
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 29 Issue 1 Table of Contents
    European Respiratory Journal: 29 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke
    S. Teramoto, H. Yamamoto, Y. Yamaguchi, Y. Hanaoka, M. Ishii, S. Hibi, Y. Ouchi
    European Respiratory Journal Jan 2007, 29 (1) 218-219; DOI: 10.1183/09031936.00115106

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke
    S. Teramoto, H. Yamamoto, Y. Yamaguchi, Y. Hanaoka, M. Ishii, S. Hibi, Y. Ouchi
    European Respiratory Journal Jan 2007, 29 (1) 218-219; DOI: 10.1183/09031936.00115106
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Clinical outcomes of bronchiectasis in India
    • Reply: Clinical outcomes of bronchiectasis in India
    • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society